Form 4 for TVGN Tevogen Inc.
Accepted 2026-07-10 17:31:31 ET · period of report 2026-07-10 · accession 0001123292-26-000995 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 17:31 | 2026-07-10 | TVGN | Saadi Ryan H. | CEO, Dir, 10% | A - Grant | $0.00 | +1.22M | 3.71M | +49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-10 | A | A | 1,220,000 | $0.00 | 3,705,689 | D | — | — | (F1) Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in four equal annual installments commencing on July 10, 2033, provided that the reporting person remains in service with the Issuer at such dates. |